Form 8-K - Current report:
SEC Accession No. 0000950103-17-004319
Filing Date
2017-05-04
Accepted
2017-05-04 16:13:27
Documents
1
Period of Report
2017-05-02
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp75901_8k.htm 8-K 28029
  Complete submission text file 0000950103-17-004319.txt   29334
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 17814074
SIC: 2834 Pharmaceutical Preparations